Dermata Therapeutics, Inc (DRMA) Misses Q2 EPS by 166c
Tweet
Share
E-mailGet Alerts DRMA Hot Sheet
Join SI Premium – FREE
Dermata Therapeutics, Inc (NASDAQ: DRMA) reported Q2 EPS of ($1.66).
For earnings history and earnings-related data on Dermata Therapeutics, Inc (DRMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- SpaceX short interest at 5-7% of float - S3 Partners
- Qualcomm (QCOM) June 26 weekly 200 and 230 calls active into investor meeting
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
